← Leaderboards
Charles H Vite
University Of Pennsylvania
$11,840,835
Attributed
$12,957,093
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,957,093 · 11
By mechanism
R01$6,539,604 · 3
P40$4,392,316 · 6
U01$1,488,344 · 1
K08$536,829 · 1
Top collaborators
- Kent Leyde2 shared
- Edward E Patterson2 shared
- Gregory A Worrell2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Mark E Haskins$13,363,758
- Donald F Patterson$2,193,382
- Robert L Barchi$510,404
- Ronald N. Harty$14,036,721
- Margret L Casal$2,448,991
Others in their field
Top investigators on “Biochemical”
- Michael W Weiner · Northern California Institute Res &Educ$74,211,055
- Bruce W Stillman · Cold Spring Harbor Laboratory$47,787,987
- John Damon Chodera · Sloan-Kettering Inst Can Research$47,159,667
- Nanduri R Prabhakar · Case Western Reserve University$46,495,566
- Richard C Boucher · University Of North Carolina Chapel Hill$44,019,683
- Peter D Karp · Sri International$43,901,053
Research focus
BiochemicalAffectEvaluationClinical TrialsProteinsAnimal ModelTranslatingFelis CatusPathologyBaseComplementary DnaFamily FelidaeClinicCessation Of LifeBrain DiseasesSafetyPathogenesisMutationResearch PersonnelCollaborationsCell DeathHereditary DiseaseDisease ProgressionImage
Grant awards (36)
Intracerebroventricular cyclodextrin and AAV-mediated gene therapy forglobal CNS disease correction in feline NPC1 disease$380,230
R01 · FY2025 · NS · contact PI
Intracerebroventricular cyclodextrin and AAV-mediated gene therapy forglobal CNS disease correction in feline NPC1 disease$393,355
R01 · FY2024 · NS · contact PI
AAV-mediated gene therapy for CNS disease correction in feline NPC1 disease$551,828
R01 · FY2023 · NS · contact PI
Referral Ctr-Animal models of human genetic disease$723,843
P40 · FY2022 · OD · contact PI
AAV-mediated gene therapy for CNS disease correction in feline NPC1 disease$551,828
R01 · FY2022 · NS · contact PI
AAV-mediated gene therapy for CNS disease correction in feline NPC1 disease$56,946
R01 · FY2022 · NS · contact PI
Referral Ctr-Animal models of human genetic disease$723,843
P40 · FY2021 · OD · contact PI
AAV-mediated gene therapy for CNS disease correction in feline NPC1 disease$566,257
R01 · FY2021 · NS · contact PI
AAV-Mediated Gene Therapy for CNS Disease Correction in Feline NPC1 Disease$139,262
R01 · FY2021 · NS · contact PI
Referral Ctr-Animal models of human genetic disease$723,843
P40 · FY2020 · OD · contact PI
Combination Therapy, Biomarkers, and Imaging in Canine Krabbe Disease$392,877
R01 · FY2020 · NS · contact PI
Referral Ctr-Animal models of human genetic disease$723,843
P40 · FY2019 · OD · contact PI
Combination Therapy, Biomarkers, and Imaging in Canine Krabbe Disease$392,877
R01 · FY2019 · NS · contact PI
Combination Therapy, Biomarkers, and Imaging in Canine Krabbe Disease$392,877
R01 · FY2018 · NS · contact PI
Referral Center-Animal models of human genetic disease$709,650
P40 · FY2017 · OD · contact PI
Combination Therapy, Biomarkers, and Imaging in Canine Krabbe Disease$485,986
R01 · FY2017 · NS · contact PI
Referral Center-Animal models of human genetic disease$709,650
P40 · FY2016 · OD · contact PI
Combination Therapy, Biomarkers, and Imaging in Canine Krabbe Disease$501,030
R01 · FY2016 · NS · contact PI
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease$350,000
R01 · FY2015 · NS · contact PI
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease$346,501
R01 · FY2014 · NS · contact PI
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease$337,750
R01 · FY2013 · NS · contact PI
Neurophysiologically Based Responsive Pharmacotherapy for Epilepsy$1
U01 · FY2013 · NS
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease$350,000
R01 · FY2012 · NS · contact PI
Neurophysiologically Based Responsive Pharmacotherapy for Epilepsy$1,488,343
U01 · FY2011 · NS
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease$350,000
R01 · FY2011 · NS · contact PI
FELINE NIEMANN - PICK TYPE C$13,429
P40 · FY2006 · RR · contact PI
FELINE ALPHA-MANNOSIDOSIS$13,429
P40 · FY2006 · RR · contact PI
MYOTONIA CONGENITA IN MINIATURE SCHNAUZERS$10,072
P40 · FY2006 · RR · contact PI
FELINE ALPHA-MANNOSIDOSIS$12,729
P40 · FY2005 · RR
MYOTONIA CONGENITA IN MINIATURE SCHNAUZERS$6,365
P40 · FY2005 · RR
FELINE ALPHA-MANNOSIDOSIS$14,413
P40 · FY2004 · RR
MYOTONIA CONGENITA IN MINIATURE SCHNAUZERS$7,207
P40 · FY2004 · RR
MRI, MIT, and MRS of MPS VII and Krabbe Disease$172,193
K08 · FY2003 · NS
MRI, MIT, and MRS of MPS VII and Krabbe Disease$172,193
K08 · FY2002 · NS
MRI, MTI AND MRS AND MPS VII AND KRABBE DISEASE$77,396
K08 · FY2002 · NS
MRI, MTI AND MRS AND MPS VII AND KRABBE DISEASE$115,047
K08 · FY2000 · NS